TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Gilead Sciences Sweden AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
313,882
|
324,679
|
234,658 |
| Financial expenses |
0
|
0
|
225 |
| Earnings before taxes |
15,238
|
15,520
|
8,213 |
| EBITDA |
14,012
|
14,346
|
8,832 |
| Total assets |
326,479
|
371,453
|
341,454 |
| Current assets |
322,900
|
367,461
|
337,122 |
| Current liabilities |
53,082
|
75,695
|
60,359 |
| Equity capital |
129,330
|
121,429
|
109,486 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
57
|
58
|
54 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
39.6%
|
32.7%
|
32.1% |
| Turnover per employee |
5,507
|
5,598
|
4,346 |
| Profit as a percentage of turnover |
4.9%
|
4.8%
|
3.5% |
| Return on assets (ROA) |
4.7%
|
4.2%
|
2.5% |
| Current ratio |
608.3%
|
485.4%
|
558.5% |
| Return on equity (ROE) |
11.8%
|
12.8%
|
7.5% |
| Change turnover |
-58
|
88,813
|
13,583 |
| Change turnover % |
0%
|
38%
|
6% |
| Chg. No. of employees |
-1
|
4
|
4 |
| Chg. No. of employees % |
-2%
|
7%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.